Diligence memo · auto-generated · as of July 2, 2026
PBR Life Sciences
PBR Life Sciences has raised $1.0M over 1 round; too few niche peers to rank its valuation yet.
Businessfiled
PBR Life Sciences operates in Data / Analytics, based in Africa. Nigerian e-health startup PBR Life Sciences has raised a US$1 million pre-seed funding round to scale its innovative data-as-a-service and analytics platform across Nigeria, Ghana, and Kenya.
Sub-sector tags: data/analytics.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
PBR Life Sciences has raised $1.0M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $1.0M on 2024-12-23.
Most recent recorded round closed around 2024-12-23.
Valuation (modeled)modeled
Provath models PBR Life Sciences at approximately $3.8M (range $660K–$11M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Too few comparable companies in this niche to rank the valuation fairly yet.
Financing rhythm & timingmixed
Last raise 18 mo ago; this sector typically re-raises about every 70 months.
Raising on or ahead of the sector's normal rhythm.
Comparablesmixed
Capital scale ranks ahead of 88% of Data / Analytics peers (41 compared).
Modeled value ranks above 78% of those peers.
Closest niche peers: Estate Intel.
Risks & flagsmixed
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.